Wells E A, Peterson P L, Gainey R R, Hawkins J D, Catalano R F
Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle 98195.
Am J Drug Alcohol Abuse. 1994;20(1):1-17. doi: 10.3109/00952999409084053.
This study sought to assess the efficacy of treatment for cocaine abuse and to compare the relative effectiveness of a cognitive-behavioral relapse prevention treatment with that of a Twelve-Step recovery support group in an outpatient group treatment setting. One hundred ten subjects seeking treatment were alternately assigned to relapse prevention or Twelve-Step treatment. Self-report data were collected at baseline, posttreatment, and 6-month follow-up. There were no differential effects of treatment type on cocaine or marijuana use over time. However, subjects in both treatment conditions reduced cocaine and marijuana use at posttreatment. Subjects in both groups reduced their alcohol use from pretreatment to posttreatment. Subjects receiving Twelve-Step treatment showed greater increases from posttreatment to 6-month follow-up in alcohol use than did relapse prevention participants. Treatment attendance was negatively related to cocaine use at posttreatment and cocaine and marijuana use at 6-month follow-up. Difficulties in conducting cocaine treatment outcome research are discussed as are treatment and research implications of the findings.
本研究旨在评估可卡因滥用治疗的疗效，并在门诊小组治疗环境中比较认知行为复发预防治疗与十二步康复支持小组的相对有效性。110名寻求治疗的受试者被交替分配到复发预防治疗组或十二步治疗组。在基线、治疗后和6个月随访时收集自我报告数据。随着时间的推移，治疗类型对可卡因或大麻使用没有差异影响。然而，两种治疗条件下的受试者在治疗后可卡因和大麻使用量均减少。两组受试者从治疗前到治疗后酒精使用量均减少。接受十二步治疗的受试者从治疗后到6个月随访时酒精使用量的增加幅度大于复发预防参与者。治疗出勤率与治疗后可卡因使用以及6个月随访时可卡因和大麻使用呈负相关。讨论了开展可卡因治疗结果研究的困难以及研究结果对治疗和研究的启示。
